# FAM221A

## Overview
FAM221A is a gene that encodes a protein belonging to the family with sequence similarity 221 member A. This protein is involved in various biological processes, although its precise functions are not fully elucidated. It has been categorized as a non-kinase protein, and its expression has been linked to several physiological and pathological conditions. Research has suggested that FAM221A may play a role in the regulation of blood pressure and glucose metabolism, as well as in the predisposition to certain cancers, such as melanoma. Despite these associations, the exact mechanisms by which FAM221A influences these processes remain an active area of investigation (Fidalgo2022Familybased; Liu2019Key; Byars2023Genetic).

## Clinical Significance
The FAM221A gene has been implicated in several conditions, although its clinical significance remains under investigation. In a study focusing on Brazilian families prone to cutaneous melanoma, a frameshift mutation in FAM221A was identified, suggesting a potential role in melanoma predisposition. However, the study did not provide detailed information on the clinical significance or known interactions of FAM221A mutations (Fidalgo2022Familybased). 

In the context of hypertension, FAM221A was identified as a hub gene in gene expression changes related to the renin-angiotensin system in spontaneously hypertensive rats. This suggests a possible involvement in blood pressure regulation, although specific clinical implications were not detailed (Byars2023Genetic).

FAM221A has also been noted to be upregulated in Type 2 Diabetes Mellitus (T2DM), but the clinical significance of this alteration is not well understood (Liu2019Key). 

Overall, while FAM221A has been associated with various conditions, including melanoma, hypertension, and diabetes, further research is needed to clarify its role and clinical significance in these diseases.

## Interactions



## References


[1. (Fidalgo2022Familybased) Felipe Fidalgo, Giovana Tardin Torrezan, Bianca Costa Soares de Sá, Bruna Durães de Figueiredo Barros, Luciana Facure Moredo, Renan Valieris, Sandro J. de Souza, João Pereira Duprat, Ana Cristina Victorino Krepischi, and Dirce Maria Carraro. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in brazilian melanoma-prone families. PLOS ONE, 17(1):e0262419, January 2022. URL: http://dx.doi.org/10.1371/journal.pone.0262419, doi:10.1371/journal.pone.0262419. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0262419)

[2. (Liu2019Key) Gao-Min Liu, Hua-Dong Zeng, Cai-Yun Zhang, and Ji-Wei Xu. Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathology - Research and Practice, 215(11):152510, November 2019. URL: http://dx.doi.org/10.1016/j.prp.2019.152510, doi:10.1016/j.prp.2019.152510. This article has 38 citations.](https://doi.org/10.1016/j.prp.2019.152510)

3. (Byars2023Genetic) Genetic reprogramming by brief inhibition of the renin-angiotensin system in spontaneously hypertensive rats leads to persistently reduced kidney renin and low blood pressure. This article has 0 citations.